FibroGen (FGEN) Tops Q4 EPS by 30c

FibroGen (NASDAQ: FGEN) reported Q4 EPS of $0.23, $0.30 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $108.1 million versus the consensus estimate of $72.1 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• Citizens launches transportation coverage, names FedEx a top large-cap pick
• Taiwan Semi (TSM) Tops Q2 EPS by 51c
• United Airlines (UAL) Tops Q2 EPS by 14c, Offers Guidance